Control yourself: ISPE‐endorsed guidance in the application of self‐controlled study designs in pharmacoepidemiology

SM Cadarette, M Maclure, JAC Delaney… - … and Drug Safety, 2021 - Wiley Online Library
Purpose Consensus is needed on conceptual foundations, terminology and relationships
among the various self‐controlled “trigger” study designs that control for time‐invariant …

Self-controlled designs in pharmacoepidemiology involving electronic healthcare databases: a systematic review

N Gault, J Castañeda-Sanabria, Y De Rycke… - BMC medical research …, 2017 - Springer
Background Observational studies are widely used in pharmacoepidemiology. Several
designs can be used, in particular self-controlled designs (case-crossover and self …

Data mining for adverse drug events with a propensity score-matched tree-based scan statistic

SV Wang, JC Maro, E Baro, R Izem, I Dashevsky… - …, 2018 - journals.lww.com
The tree-based scan statistic is a statistical data mining tool that has been used for signal
detection with a self-controlled design in vaccine safety studies. This disproportionality …

Evaluating the use of methods to mitigate bias from non‐transient medications in the case‐crossover design: A systematic review

HC Huang, WC Li, M Tadrous… - … and Drug Safety, 2023 - Wiley Online Library
Purpose The case‐crossover design is a self‐controlled study design used to compare
exposure immediately preceding an event occurrence with exposure in earlier control …

Risk of parkinsonism and related movement disorders with gabapentinoids or tramadol: A case‐crossover study

K Ri, T Fukasawa, S Yoshida… - … : The Journal of …, 2023 - Wiley Online Library
Introduction A safety signal concerning parkinsonism and related movement disorders with
gabapentinoids (gabapentin and pregabalin) or tramadol was detected by reviewing …

A Case‐Crossover–Based Screening Approach to Identifying Clinically Relevant Drug–Drug Interactions in Electronic Healthcare Data

K Bykov, S Schneeweiss, RJ Glynn… - Clinical …, 2019 - Wiley Online Library
We sought to develop a semiautomated screening approach using electronic healthcare
data to identify drug–drug interactions (DDIs) that result in clinical outcomes. Using a case …

Bias in case‐crossover studies of medications due to persistent use: a simulation study

K Bykov, SV Wang, J Hallas, A Pottegård… - … and drug safety, 2020 - Wiley Online Library
Purpose The case‐crossover design is increasingly used to evaluate the effects of chronic
medications; however, as traditionally implemented in pharmacoepidemiology, with referent …

[HTML][HTML] Risk management in techno vigilance: analysis of reports from a sentinel hospital

RS Sousa, LPP Pontes, JLB Maia… - Rev. enferm. UERJ …, 2017 - e-publicacoes.uerj.br
Objective: to evaluate and analyze health product-related technical complaints and adverse
events at Maranhão Federal University Hospital. Methods: from January to December 2015 …

High-Throughput Computing to Automate Population-Based Studies to Detect the 30-Day Risk of Adverse Outcomes After New Outpatient Medication Use in Older …

SS Abdullah, N Rostamzadeh… - … Journal of Kidney …, 2024 - journals.sagepub.com
Background: Safety issues are detected in about one third of prescription drugs in the years
following regulatory agency approval. Older adults, especially those with chronic kidney …

[HTML][HTML] Comparison of different case-crossover variants in handling exposure-time trend or persistent-user bias: using dipeptidyl peptidase-4 inhibitors and the risk of …

YH Dong, SV Wang, JJ Gagne, LC Wu, CH Chang - Value in Health, 2020 - Elsevier
Objectives Inappropriate use of the case-crossover design, which is efficient for examining
associations between brief exposure and abrupt outcomes, in evaluating the effects of …